Related Experiment Video
Updated: Mar 16, 2026
Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach
Published on: September 26, 2019
Atopic Dermatitis: Update for Pediatricians
Insights
Early emollient use in infants may prevent atopic dermatitis (AD), a common inflammatory skin condition. This approach addresses skin barrier dysfunction, a key factor in AD development and severity.
Area of Science:
- Dermatology
- Pediatrics
- Genetics
Background:
- Atopic dermatitis (AD) is a prevalent chronic inflammatory skin condition affecting up to 20% of children.
- Skin barrier dysfunction is increasingly recognized as central to AD pathogenesis.
- Filaggrin gene mutations are a significant predisposing factor for AD development.
Purpose of the Study:
- To review current understanding of atopic dermatitis pathogenesis and management.
- To highlight the role of skin barrier function and genetic factors.
- To discuss preventative strategies for AD.
Main Methods:
- Literature review of recent advances in atopic dermatitis research.
- Analysis of the role of filaggrin in epidermal barrier maintenance.
- Evaluation of treatment strategies for eczema symptoms.
Main Results:
- Genetic defects in filaggrin compromise the epidermal barrier, increasing AD risk.
- Effective AD management involves emollients, anti-inflammatory agents, and infection control (e.g., diluted bleach baths).
- Emerging evidence suggests early emollient application from birth can prevent AD onset.
Conclusions:
- Addressing skin barrier dysfunction is crucial for managing and potentially preventing atopic dermatitis.
- A multi-faceted approach including emollients, anti-inflammatories, and infection control is recommended for AD treatment.
- Proactive skincare, such as early emollient use, shows promise in preventing AD in infants.
Abstract:
Atopic dermatitis (AD) is a chronic, relapsing inflammatory skin disorder present in up to 20% of children. Recent advances implicate skin barrier dysfunction as central to disease pathogenesis. Genetic defects in the filaggrin gene, the product of which is important for maintaining the epidermal barrier, are a strong predisposing factor in the development of AD. In addition to reducing identifiable triggers, treatment should focus on the four clinical characteristics of eczema: emollients for dry skin, topical anti-inflammatory agents to reduce inflammation and itch, and strategies to reduce infection/colonization, which can include diluted bleach baths. New studies demonstrate that early emollient application from birth may prevent development of AD. [Pediatr Ann. 2016;45(8):e280-e286.].
Related Concept Videos
01:20Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
01:30Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
01:26Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
01:24Asthma-III: Symptoms and Complications
Classification of Asthma
01:29Asthma-I: Introduction